欢迎访问上海交通大学BIO-X研究院!
李丹

博士,教授,课题组长,博导

学    士 (1998-2002) 吉林大学
博    士 (2002-2008) 北京大学
博士后(2008-2013) 加州大学洛杉矶分校(UCLA)/霍华德休斯医学院 博士后

Email:lidan2017@sjtu.edu.cn

个人介绍

李丹博士聚焦蛋白相分离和相变,开发基于冷冻电镜的电子衍射、螺旋纤维成像、in-cell核磁等前沿技术,研究蛋白分相正常生理功能的原子分子基础,及蛋白淀粉样相变导致神经退行性疾病的原子分子基础。

研究方向

蛋白相分离和相变、神经退行性疾病

方向1: 综合运用多种生物物理、生物化学和细胞生物学手段,研究生理和病理条件下的蛋白质相分离和无膜细胞器的组装与调控。

方向2: 研究神经退行性疾病,如阿尔兹海默症(AD)、帕金森症(PD)、渐冻人症(ALS)等,蛋白异常相变聚集的发生和致病机理。发展运用冷冻电镜电子衍射、螺旋纤维三维重构技术,解析蛋白淀粉样聚集纤维原子结构,阐释聚集体致病的分子机理, 开发相关疾病的治疗药物和临床诊断标记物。

代表性论文

2020

1. Zhao, K., Li, Y., Liu, Z., Long, H., Zhao, C., Luo, F., Sun, Y., Tao, Y., Su, X.-D., Li, D.#, Li, X.#, Liu, C.#, Parkinson’s disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure. Nature Communications, 2020 In press.

2. Lu J, Zhang S, Ma X, Jia C, Liu Z, Huang C, Liu C#, Li D.#, Structural basis of the interplay between α-synuclein and Tau in regulating pathological amyloid aggregation. J. Biol. Chem. 2020 Apr 13. pii: jbc.RA119.012284. doi: 10.1074/jbc.RA119.012284. [Epub ahead of print]

3. Ma X, Zhu Y, Lu J, Xie J, Li C, Shin WS, Qiang J, Liu J, Dou S, Xiao Y, Wang C, Jia C, Long H, Yang J, Fang Y, Jiang L, Zhang Y, Zhang S, Zhai RG#, Liu C#, Li D.#, Nicotinamide mononucleotide adenylyltransferase uses its NAD+ substrate-binding site to chaperone phosphorylated Tau. Elife. 2020 Apr 6;9. pii: e51859. doi: 10.7554/eLife.51859.

4. Sun, Y., Hou, S., Zhao, K., Long, H., Liu, Z., Gao, J., Zhang, Y., Su, X. D., Li, D.#, Liu, C.#. Cryo-EM structure of full-length α-synuclein amyloid fibril with Parkinson’s disease familial A53T mutation, Cell Research, 2020 Apr;30(4):360-362. doi: 10.1038/s41422-020-0299-4.

5. Wang, C., Tu, J., Zhang, S., Cai, B., Liu, Z., Hou, S., Zhong, Q., Hu, X., Liu, W., Li, G., Liu, Z., He, L., Diao, J., Zhu, Z. J., Li, D.#, Liu, C.#, Different regions of synaptic vesicle membrane regulate VAMP2 conformation for the SNARE assembly. Nature Communications. 2020 Mar 24;11(1):1531. doi: 10.1038/s41467-020-15270-4.

6. Liu, Z., Zhang S., Gu, J., Tong, Y., Li, Y., Gui, X., Long, H., Wang, C., Zhao, C., Lu, J., Lin, H., Li, Y., Liu, Z., Li, D.#, Liu, C.#, Hsp27 chaperones FUS phase separation under the modulation of stress-induced phosphorylation. Nature Structural and Molecular Biology. 2020 Apr;27(4):363-372. doi: 10.1038/s41594-020-0399-3.

7. Li, D.#, Liu, C.#, Structural Diversity of Amyloid Fibrils and Advances in Their Structure Determination. Biochemistry, 2020 Feb 11;59(5):639-646. doi: 10.1021/acs.biochem.9b01069.


2019

8. Jia, C., Ma, X., Liu, Z., Gu, J., Zhang, X., Li, D.#, Zhang, S.#, Different heat shock proteins bind α-synuclein with distinct mechanisms and synergistically prevent its amyloid aggregation. Frontiers in Neuroscience, 2019 November 1, volume 13, doi: 10.3389/fnins.2019.01124

9. Gui, X., Luo, F., Li, YC, Zhou, H., Qin,Z., Liu, ZY, Gu, JG, Xie, MY, Zhao, K., Dai, B., Shin, WS, He, JH, He, L., Jiang, L., Zhao, ML, Sun, B., Li, XM, Liu, C.#, Li, D.# Structural basis for reversible amyloids of hnRNPA1 elucidates their role in stress granule assembly, Nature Communications, 2019 May 1;10(1):2006.

10. Lu, J., Cao, Q., Wang, C., Zheng, J., Luo, F., Xie, J., Li, Y., Ma, X., He, L., Eisenberg, D., Nowick, J., Jiang, L.#, Li, D.#, Structure-Based Peptide Inhibitor Design of Amyloid-b Aggregation, Frontiers in Molecular Neuroscience, 2019 Mar 4;12:54.


2018

11. Li, Y., Zhao, C., Luo, F., Liu, Z., Gui, X., Luo, Z., Zhang, X., Li, D.#, Liu, C.#, Li, X.# Amyloid fibril structure of alpha-synuclein determined by cryo-electron microscopy. Cell Research 2018 Sep;28(9):897-903.

12. Li, D.#, Liu, C.#. Better together: a hybrid amyloid signals necroptosis. Cell 2018 Volume 173, Issue 5, p1068–1070, 17 May.

13. Luo, F., Gui, X., Zhou, H., Gu, J., Li, Y., Liu, X., Zhao, M., Li, D.#, Li, X.#, Liu, C.#. Atomic structures of FUS LC domain segments reveal bases for reversible amyloid fibril formation. Nature Struct. Mol. Biol. 2018 Apr;25(4):341-346

#并列通讯作者